Aminoglutethimide

Back to search

Molecule Structure

Scientific Name

Aminoglutethimide

Description of the Drug

Aminoglutethimide is an adrenocortical steroid synthesis inhibitor used in the treatment of Cushing’s syndrome.

Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB00357

Brand Name(s)

Cytadren, Orimeten

Company Owner(s)

Novartis Pharmaceuticals Corp

Mechanism(s) Of Action

Target Name Target Type Action Type Target ChEMBL ID
Cytochrome P450 19A1 SINGLE PROTEIN INHIBITOR CHEMBL1978
Cytochrome P450 11A1 SINGLE PROTEIN INHIBITOR CHEMBL2033

Unichem Links

SureChEMBL SCHEMBL4306
PharmGKB PA448375
Human Metabolome Database HMDB0014501
DrugBank DB00357
PubChem: Thomson Pharma 15068844
PubChem 2145
Mcule MCULE-9118268281
NMRShiftDB 60062198
LINCS LSM-1409
Nikkaji J5.378C
BindingDB 9460
EPA CompTox Dashboard DTXSID8022589
DrugCentral 164
Brenda 15629 124968
ChemicalBook CB5131691
Guide to Pharmacology 7054
rxnorm AMINOGLUTETHIMIDE
PubChem: Drugs of the Future 12012594
KEGG Ligand C07617
ChEBI 2654